Companies: 11,345     total market cap: โ‚ฌ135.774 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novartis
NVS
#57
Rank
โ‚ฌ242.49 B
Marketcap
๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Country
127,58ย โ‚ฌ
Share price
-0.15%
Change (1 day)
12.81%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Net assets

Net assets on the balance sheet as of June 2026 : โ‚ฌ37.40 Billion

According to Novartis's latest financial reports the company has โ‚ฌ37.40 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novartis - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$โ‚ฌ39.62 B-6.55%
2024-12-31$โ‚ฌ42.40 B0.27%
2023-12-31$โ‚ฌ42.29 B-23.66%
2022-12-31$โ‚ฌ55.39 B-7.5%
2021-12-31$โ‚ฌ59.88 B29.99%
2020-12-31$โ‚ฌ46.07 B-7.1%
2019-12-31$โ‚ฌ49.58 B-27.91%
2018-12-31$โ‚ฌ68.78 B11.19%
2017-12-31$โ‚ฌ61.86 B-13.11%
2016-12-31$โ‚ฌ71.19 B0.94%
2015-12-31$โ‚ฌ70.53 B21.09%
2014-12-31$โ‚ฌ58.25 B8.02%
2013-12-31$โ‚ฌ53.92 B2.99%
2012-12-31$โ‚ฌ52.36 B3.12%
2011-12-31$โ‚ฌ50.77 B-3.2%
2010-12-31$โ‚ฌ52.45 B30.78%
2009-12-31$โ‚ฌ40.10 B11.17%
2008-12-31$โ‚ฌ36.07 B6.64%
2007-12-31$โ‚ฌ33.83 B8.1%
2006-12-31$โ‚ฌ31.29 B11.78%
2005-12-31$โ‚ฌ27.99 B21.27%
2004-12-31$โ‚ฌ23.08 B-4.77%
2003-12-31$โ‚ฌ24.24 B-10.57%
2002-12-31$โ‚ฌ27.10 B-6.34%
2001-12-31$โ‚ฌ28.93 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ75.77 B 102.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ76.24 B 103.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ46.99 B 25.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ70.80 B 89.29%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ37.44 B 0.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ19.90 B-46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ44.91 B 20.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ20.29 B-45.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ6.91 B-81.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com